FDA has designated a recent fault in St. Jude Medical Inc.'s manufacturing process for its Optisure defibrillation lead as a high-risk, class I recall action.
The recall
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?